Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01962896 |
| Title | A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Theodore Laetsch |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | United States | Details | |
| UT Southwestern Medical Center/Children's Medical Center | Dallas | Texas | 75390 | United States | Details |